http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180049265-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c12a2a7eaad13b30d27ce6da591256 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00 |
| filingDate | 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc9c71f08d3ddf49f95c20e126f7f8f |
| publicationDate | 2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180049265-A |
| titleOfInvention | Fruit extracts |
| abstract | The present invention relates to a method for preparing fruit extract of a branch, wherein the fruit is treated to optimize the platelet aggregation inhibitory activity of the extract. The method comprises the steps of: preparing a starting mix of uniform fruits; Separating the soluble fraction from the fruit solids; Filtering the water-soluble fraction; And concentrating the active substances in the filtrate. The present invention relates to fruit extracts and glycosylated phenolic acid or phenolic acid esters or derivatives thereof prepared by this method; A fruit extract comprising a glycosylated flavonoid and a nucleoside is provided. The extract of the present invention is useful as a medicament for the treatment or prevention of diseases characterized by inappropriate platelet aggregation. In particular, the medicament may be used for the treatment or prevention of diseases characterized by inappropriate platelet aggregation to reduce platelet aggregation to maintain cardiac health; To benefit the cycle; May be useful for normalizing or benefiting blood flow. |
| priorityDate | 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.